An experimental pill may work just as well as injectable, Ozempic-style drugs at treating type 2 diabetes, early trial results suggest.
The oral medication, called orforglipron, belongs to a class of drugs called glucagon-like peptide 1 (GLP-1) agonists. This class also includes Ozempic, which is made by Novo Nordisk and approved as a blood-sugar control aid in type 2 diabetes, as well as a treatment for people with type 2 and either heart disease or kidney disease. It also includes Wegovy, which has the same active ingredient as Ozempic but is approved for chronic weight management.
